StonvexLoading…
StonvexStonvexStonvexCore line items from AOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.83B | $3.82B | $3.85B | $3.75B |
Operating Income | $728.60M | $707.70M | $745.50M | $362.00M |
Net Income | $546.20M | $533.60M | $556.60M | $235.70M |
EPS (Diluted) | $3.85 | $3.63 | $3.69 | $1.51 |
Total Assets | $3.14B | $3.24B | $3.21B | $3.33B |
Total Liabilities | $1.28B | $1.36B | $1.37B | $1.58B |
Cash & Equivalents | $174.50M | $239.60M | $339.90M | $391.20M |
Free Cash Flow OCF − CapEx | $546.00M | $473.80M | $597.70M | $321.10M |
Shares Outstanding | 141.91M | 147.08M | 151.02M | 155.78M |